Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1ФГБНУ Научный центр психического здоровья. 115522, Россия, Москва, Каширское ш., д. 34; 2ФГБОУ ВО Первый Московский государственный медицинский университет им. И.М.Сеченова Минздрава России. 119991, Россия, Москва, ул. Трубецкая, д. 8, стр. 2
M.R.Shafigullin1, D.S.Petelin1,2 1 Mental Health Research Centre. 115522, Russian Federation, Moscow, Kashirskoe sh., d. 34; 2 I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation. 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2
Список исп. литературыСкрыть список 1. Бохян В.Ю., Бельцевич Д.Г., Вашакмадзе Л.А. и др. Клинические рекомендации по лечению нейроэндокринных опухолей. М., 2014. / Bokhyan V.Yu., Bel'tsevich D.G., Vashakmadze L.A. et al. Klinicheskie rekomendatsii po lecheniiu neiroendokrinnykh opukholei. M., 2014. [in Russian] 2. Baba M, Ray D. Severe psychosis due to Cushing's syndrome in a patient with a carcinoid tumour in the lung: a case report and review of the current management. World J Surg Oncol 2015; 13: 165. 3. Baiwah S, Lee B. The case study master class. Case 20% symptom control in patient with carcinoid tumor. Eur J Palliative Care 2005; 12: 106–7. 4. Bariani G, Carvalheira J, Riechelmann R. Antitumor effect of everolimus in a patient with type 3 gastric neuroendocrine tumor. Onkologie 2013; 36 (9): 502–4. 5. Chambers A, Longman R, Pasieka J. Impairment of cognitive function reported by patients suffering from carcinoid syndrome. World J Surg 2010; 34 (6): 1356–60. 6. Curzon G. Tryptophan pyrrolase – a biochemical factor in depressive illness. Br J Psychiatry 1969; 113: 1367–74. 7. Edge J, Panieri E. Phaeochromocytoma – a classic (but easily forgotten) cause of anxiety. Afr J Psychiatry (Johannesbg) 2011; 14 (2): 154–56. 8. Engelmann K, Lovenberg W, Sjoerdsma A. Inhibition of serotonin synthesis by para-chlorophenylalanine in patients with the carcinoid syndrome. N Engl J Med 1967; 277 (21): 1103–8. 9. Eriksson B, Oberg K. Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors: future outlook. Ann Oncol 1999; 10 (2): 31–8. 10. Frojd C, Lampic C, Larsson G et al. Is satisfaction with doctors' care related to health-related quality of life, anxiety and depression among patients with carcinoid tumours? A longitudinal report. Scand J Caring Sci 2009; 23 (1): 107–16. 11. Furse R, Green C, Mee A. Carcinoid syndrome unmasked by fluoxetine, a selective serotonin reuptake inhibitor. Clin Gastroenterol Hepatol 2008; 6 (8): e27–8. 12. Grahame-Smith D. The carcinoid syndrome. Am J Cardiol 1968; 21 (3): 376–87. 13. Horst-Schrivers A, Wymenga A, Links T et al. Complication of midgut carcinoid tumors and carcinoid syndrom. Neuroendocrinology 2004; 80 (1): 28–32. 14. Janson I, Holmberg E, Strdsberg R et al. Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center. Ann Oncol 1997; 8 (7): 685–90. 15. Larsson G, Haguind K, Von Essen L. Distress, quality of life and strategies to 'keep a good mood' in patients with carcinoid tumours: patient and staff perceptions. Eur J Cancer Care (Engl) 2003; 12 (1): 46–57. 16. Lehmann J. Mental disturbancies followed by stupor in a patient with carcinoid. Acta Psychiatr Scand 1966; 42: 153–61. 17. Major L, Brown G, Wilson W. Carcinoid and psychiatric symptoms. South Med J 1973; 66 (7): 787–90. 18. Modlin I, Shapiro M, Kidd M. Siegfried Oberndorfer: Origins and perspectives of carcinoid tumors. Hum Pathol 2004; 35 (12): 1440–51. 19. Moretti P, Dennis J, Stella A et al. Comorbility between anxiety and depression in patients with carcinoid tumors. Rivisita di Psichiatria 2013; 48 (4): 301–6. 20. Noblett J. The presence and management of depression in patients with carcinoid. BMJ 2010; 341: 39–41. 21. Norheim I, Oberg K, Theodorsson-Norheim T et al. Malignant carcinoid tumors. An analysis of 103 patients with regard to tumor localization, hormone production, and survival. Ann Surg 1987; 206 (2): 115–25. 22. Noyer C, Schwartz B. Sertraline, a selective serotonin reuptake inhibitor, unmasking carcinoid syndrome. Am J Gastroenterol 1997; 92 (8): 1387–8. 23. Oberg K, Castellano D. Current knowledge on diagnosis and staging of neuroendocrine tumors. Cancer Metast Rev 2011; 30: 3–7. 24. Pasieka J, Longman R, Chambers A et al. Cognitive impairment associated with carcinoid syndrome. Ann Surg 2014; 259 (2): 355–9. 25. Patchell R, Posner J. Neurologic complications of carcinoid. Neurology 1986; 36 (6): 745–9. 26. Pearse A. The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept. J Histochem Cytochem 1969; 17 (5): 303–13. 27. Russo S, Boon J, Kema I et al. Patients with carcinoid syndrome exhibit symptoms of aggressive impulse dysregulation. Psychosom Med 2004; 66 (3): 422–5. 28. Savitz J, Dantzer R, Wurfel B. Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder. Psychoneuroendocrinology 2015; 52: 200–11. 29. Shoukry H. Carcinoid syndrom associated with psychosis. Postgrad Med 1965; 41: 566–7. 30. Simbera Z, Balon R. Carcinoid tumor, selective serotonin reuptake inhibitors, and diarrhea. Psychosomatics 2005; 46 (1): 88–9. 31. Sokoloff B. Recent results in cancer research. Carcinoid and serotonin. Springer Verlag 1968; 15: 34–43. 32. Thorson A. Studies on carcinoid disease. Acta Med Scand 1958; 161: 1–146. 33. Warner R. Enteroendocrine Tumors Other Than Carcinoid: A Review of Clinically Significant Advances. Gastroenterology 2005; 128 (6): 1668–84. 34. Williams M, Dolenc T. Selective serotonin reuptake inhibitors and patients with carcinoid tumor. Psychosomatics 2005; 46 (4): 370–2. 35. Wooley O. The biochemical basis of psychosis. New-York: John Wiley & Sons, 1962. 36. Yazıcıoğlu A, Yekeler E, Bıcakcıoğlu P et al. Synchronous bilateral multiple typical pulmonary carcinoid tumors: a unique case with 10 typical carcinoids. Balkan Med J 2012; 29 (4): 450–2.